Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Gutermuth

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Allergy|February 4, 2021
EAACI Biologicals Guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitisIoana Agache, Cezmi A Akdis, Mubeccel Akdis, et al.
Allergy|July 29, 2021
EAACI Biologicals Guidelines-Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years oldIoana Agache, Cezmi A Akdis, Mubeccel Akdis, et al.
BMJ Open|July 11, 2025
European, multicentre, prospective observational phase IV clinical study to assess the impact of lebrikizumab on health-related well-being and control of skin manifestations in patients with moderate-to-severe atopic dermatitis (ADTrust): study protocolMatthias Augustin, Anthony Bewley, Marie-Charlotte Brüggen, et al.
Allergy|July 22, 2020
Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelinesIoana Agache, Yang Song, Margarita Posso, et al.
Allergy|August 9, 2020
Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals GuidelinesIoana Agache, Claudio Rocha, Ana Pereira, et al.
Nature Communications|November 26, 2024
Multiomics approaches disclose very-early molecular and cellular switches during insect-venom allergen-specific immunotherapy: an observational studyDimitrii Pogorelov, Sebastian Felix Nepomuk Bode, Xin He, et al.
Allergy|August 5, 2024
Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declarationClaudia Traidl-Hoffmann, Jamie Afghani, Cezmi A Akdis, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Allergy|February 4, 2021
EAACI Biologicals Guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitisIoana Agache, Cezmi A Akdis, Mubeccel Akdis, et al.
Allergy|July 29, 2021
EAACI Biologicals Guidelines-Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years oldIoana Agache, Cezmi A Akdis, Mubeccel Akdis, et al.
BMJ Open|July 11, 2025
European, multicentre, prospective observational phase IV clinical study to assess the impact of lebrikizumab on health-related well-being and control of skin manifestations in patients with moderate-to-severe atopic dermatitis (ADTrust): study protocolMatthias Augustin, Anthony Bewley, Marie-Charlotte Brüggen, et al.
Allergy|July 22, 2020
Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelinesIoana Agache, Yang Song, Margarita Posso, et al.
Allergy|August 9, 2020
Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals GuidelinesIoana Agache, Claudio Rocha, Ana Pereira, et al.
Nature Communications|November 26, 2024
Multiomics approaches disclose very-early molecular and cellular switches during insect-venom allergen-specific immunotherapy: an observational studyDimitrii Pogorelov, Sebastian Felix Nepomuk Bode, Xin He, et al.
Allergy|August 5, 2024
Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declarationClaudia Traidl-Hoffmann, Jamie Afghani, Cezmi A Akdis, et al.
Pageof 8